Xinhui Wu

Ms. Xinhui Wu

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2024 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
SSShanshan Song
Shanshan Song
FDFransien van Dijk
Fransien van Dijk
GVGwenda F. Vasse
Gwenda F. Vasse
QLQiongliang Liu
Qiongliang Liu
IGIrene F. Gosselink
Irene F. Gosselink
BMBarbro N. Melgert
Barbro N. Melgert
Rationale: Microplastics are a pressing global concern, and inhalation of microplastic fibers has been associated with interstitial and bronchial inflammation in flock workers. However, how microplastic fibers affect the lungs is unknown. Objectives: Our aim was to assess the effects of 12 × 31 μm nylon 6,6 (nylon) and 15 × 52 μm polyethylene terephthalate (polyester) textile microplastic fibers on lung epithelial growth and differentiation. Methods: We used human and murine alveolar and airway-type organoids as well as air–liquid interface cultures derived from primary lung epithelial progenitor cells and incubated these with either nylon or polyester fibers or nylon leachate. In addition, mice received one dose of nylon fibers or nylon leachate, and, 7 days later, organoid-forming capacity of isolated epithelial cells was investigated. Measurements and Main Results: We observed that nylon microfibers, more than polyester, inhibited developing airway organoids and not established ones. This effect was mediated by components leaching from nylon. Epithelial cells isolated from mice exposed to nylon fibers or leachate also formed fewer airway organoids, suggesting long-lasting effects of nylon components on epithelial cells. Part of these effects was recapitulated in human air–liquid interface cultures. Transcriptomic analysis revealed upregulation of Hoxa5 after exposure to nylon fibers. Inhibiting Hoxa5 during nylon exposure restored airway organoid formation, confirming Hoxa5’s pivotal role in the effects of nylon. Conclusions: These results suggest that components leaching from nylon 6,6 may especially harm developing airways and/or airways undergoing repair, and we strongly encourage characterization in more detail of both the hazard of and the exposure to microplastic fibers.

25 September 2019 in Cells
Verified
Journal Article
Open access
PDF file
XWXinhui Wu
Xinhui Wu
EDEline M. van Dijk
Eline M. van Dijk
JNJohn-Poul Ng-Blichfeldt
John-Poul Ng-Blichfeldt
IBI. Sophie T. Bos
I. Sophie T. Bos
CCChiara Ciminieri
Chiara Ciminieri
RGReinoud Gosens
Reinoud Gosens
Chronic obstructive pulmonary disease (COPD) represents a worldwide concern with high morbidity and mortality, and is believed to be associated with accelerated ageing of the lung. Alveolar abnormalities leading to emphysema are a key characteristic of COPD. Pulmonary alveolar epithelial type 2 cells (AT2) produce surfactant and function as progenitors for type 1 cells. Increasing evidence shows elevated WNT-5A/B expression in ageing and in COPD that may contribute to the disease process. However, supportive roles for WNT-5A/B in lung regeneration were also reported in different studies. Thus, we explored the role of WNT-5A/B on alveolar epithelial progenitors (AEPs) in more detail. We established a Precision-Cut-Lung Slices (PCLS) model and a lung organoid model by co-culturing epithelial cells (EpCAM+/CD45-/CD31-) with fibroblasts in matrigel in vitro to study the impact of WNT-5A and WNT-5B. Our results show that WNT-5A and WNT-5B repress the growth of epithelial progenitors with WNT-5B preferentially restraining the growth and differentiation of alveolar epithelial progenitors. We provide evidence that both WNT-5A and WNT-5B negatively regulate the canonical WNT signaling pathway in alveolar epithelium. Taken together, these findings reveal the functional impact of WNT-5A/5B signaling on alveolar epithelial progenitors in the lung, which may contribute to defective alveolar repair in COPD.

25 March 2022 in Science Advances
Verified
Journal Article
Open access
XWXinhui Wu
Xinhui Wu
IBI. Sophie T. Bos
I. Sophie T. Bos
TCThomas M. Conlon
Thomas M. Conlon
MAMeshal Ansari
Meshal Ansari
VVVicky Verschut
Vicky Verschut
RGReinoud Gosens
Reinoud Gosens
Currently, there is no pharmacological treatment targeting defective tissue repair in chronic disease. Here, we used a transcriptomics-guided drug target discovery strategy using gene signatures of smoking-associated chronic obstructive pulmonary disease (COPD) and from mice chronically exposed to cigarette smoke, identifying druggable targets expressed in alveolar epithelial progenitors, of which we screened the function in lung organoids. We found several drug targets with regenerative potential, of which EP and IP prostanoid receptor ligands had the most profound therapeutic potential in restoring cigarette smoke–induced defects in alveolar epithelial progenitors in vitro and in vivo. Mechanistically, we found, using single-cell RNA sequencing analysis, that circadian clock and cell cycle/apoptosis signaling pathways were differentially expressed in alveolar epithelial progenitor cells in patients with COPD and in a relevant model of COPD, which was prevented by prostaglandin E2 or prostacyclin mimetics. We conclude that specific targeting of EP and IP receptors offers therapeutic potential for injury to repair in COPD.

12 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
HHHabibie Habibie
Habibie Habibie
SSShanshan Song
Shanshan Song
CBCarian E Boorsma
Carian E Boorsma
KPKurnia S.S. Putri
Kurnia S.S. Putri
CRCatharina Reker-Smit
Catharina Reker-Smit
BMBarbro N. Melgert
Barbro N. Melgert
Receptor activator for NF-κβ (RANK) ligand (RANKL) is found in lung tissue and elevated in lung diseases like chronic obstructive pulmonary disease (COPD), cystic fibrosis and silica-induced pulmonary fibrosis. RANKL is a well-known stimulator of bone tissue degradation, which may explain the association between these lung diseases and osteoporosis. However, RANKL is also reported to be involved in epithelial cell regeneration in breast and thymus. We hypothesized that RANKL, which is produced directly in lung tissue, is involved in the regeneration of lung epithelial cells. Therefore, we aimed to clarify the specific role of RANKL in this process. Using an organoid model of lung epithelial development by co-culturing primary EpCAM+ lung epithelial cells with fibroblasts, we found higher numbers of alveolar organoids after soluble RANKL treatment compared to control. Importantly, this effect was similar in human RANKL-treated organoids derived from epithelial cells isolated from lung tissue of COPD patients. The effect of RANKL was abrogated upon addition of osteoprotegerin, the soluble inhibitor of RANKL. We also found that RANKL stimulated phosphorylation of Akt suggesting involvement of its receptor RANK in the signaling pathway. Moreover, in vivo RANKL administration resulted in more type II alveolar epithelial cells in lungs of mice with silica-induced pulmonary fibrosis. In conclusion, we found that RANKL promotes type II alveolar epithelial cell regeneration and may therefore be a novel contributor to lung tissue repair. New and Noteworthy: Our study provides compelling evidence demonstrating an as of yet unknown function of receptor activator for NF-κβ ligand (RANKL) in lung tissue regeneration. We found that RANKL plays a role in the regeneration of lung epithelial cells, particularly type II alveolar epithelial cells. This may also have clinical implications as promotion of alveolar epithelial cell regeneration may enhance lung tissue repair, an important target in patients with lung diseases like COPD and fibrosis.

18 May 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
XWXinhui Wu
Xinhui Wu
IBI. Sophie T. Bos
I. Sophie T. Bos
TCThomas M. Conlon
Thomas M. Conlon
MAMeshal Ansari
Meshal Ansari
VVVicky Verschut
Vicky Verschut
RGReinoud Gosens
Reinoud Gosens
Currently, there is no pharmacological treatment targeting defective tissue repair in chronic disease. Here we utilized a transcriptomics-guided drug target discovery strategy using gene signatures of smoking-associated chronic obstructive pulmonary disease (COPD) and from mice chronically exposed to cigarette smoke, identifying druggable targets expressed in alveolar epithelial progenitors of which we screened the function in lung organoids. We found several drug targets with regenerative potential of which EP and IP prostanoid receptor ligands had the most significant therapeutic potential in restoring cigarette smoke-induced defects in alveolar epithelial progenitors in vitro and in vivo . Mechanistically, we discovered by using scRNA-sequencing analysis that circadian clock and cell cycle/apoptosis signaling pathways were enriched in alveolar epithelial progenitor cells in COPD patients and in a relevant model of COPD, which was prevented by PGE2 or PGI2 mimetics. Conclusively, specific targeting of EP and IP receptors offers therapeutic potential for injury to repair in COPD.

28 September 2019 in European Respiratory Journal
Verified
Conference Paper
Closed access
XWXinhui Wu
Xinhui Wu
SBSophie Bos
Sophie Bos
Martina SchmidtMartina Schmidt
Martina Schmidt
LKLoes Kistemaker
Loes Kistemaker
RGReinoud Gosens
Reinoud Gosens
Background: COPD is characterized by irreversible airflow limitation. Though studies indicate causative roles of cigarette smoke/air pollution in provoking the development of COPD, the precise impact of these factors on lung progenitors is unclear. We hypothesized cigarette smoke and diesel particles might reduce the functionality of lung epithelial progenitors. Methods: Murine lung organoids were set up by co-culturing epithelial cells (EpCAM+/CD45-/CD31-) with CCL206 fibroblasts in Matrigel. Organoids were exposed to different concentrations of Cigarette Smoke Extract (CSE) or Diesel Exhaust Particles (DEP) throughout entire culture period. Results: The number of organoids observed on day 7 was significantly decreased by 5% CSE and by 200 μg/mL DEP, yet slightly increased by 50 and 100 μg/mL DEP. CSE had no effect on the number of airway type organoids by day 14, but they were significantly increased by 50 and 100 μg/mL DEP, and decreased by 200 μg/mL DEP. The number of alveolar type organoids was significantly decreased by both 5% CSE and by 200 μg/mL DEP. Immunofluorescence studies showed the number of acetylated-α tubulin+ and pro-SPC+ organoids were significantly decreased by 5% CSE and by 200 μg/mL DEP respectively. The size of airway type organoids was significantly smaller in response to 5% CSE. Both 5% CSE and 200 μg/mL DEP significantly reduced the size of alveolar type organoids by day 14. Conclusion: Cigarette smoke and diesel particles functionally inhibit lung organoid formation by epithelial progenitors. Alveolar organoid formation was particularly more sensitive to these exposures. We speculate such a mechanism may contribute to defective alveolar repair in COPD.